Our solutions enable you to minimize risks in drug development, streamline productivity and lower cost across key aspects of pre-clinical and clinical development, Portfolio Strategy, and Business Development.
Mispriced risk: Finding undervalued biopharma business development opportunities
AI can deliver better healthcare and longevity for all. Here's how.
Intelligencia Raises $12M to Reduce the Risk of Clinical Research, Improve R&D Productivity, and Accel erate Scientific Breakthroughs
Intelligencia.ai: Machine learning: A Catalyst for Drug Development
Take the risk out of clinical drug development
Optimizing Real World Data for Therapeutic Development: The Role of Artificial Intelligence
Dimitrios Skaltsas: AI at the heart of drug-development company